Targeting PI3K/Akt/mTOR Cascade: The Medicinal Potential, Updated Research Highlights and Challenges Ahead

E-ISSN： 1875-533x|20|24|2991-3010

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.20, Iss.24, 2013-08, pp. : 2991-3010

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the PI3K/AKT/mTOR Signaling Axis in Children with Hematologic Malignancies

By Barrett David Brown Valerie I. Grupp Stephan A. Teachey David T.

Pediatric Drugs, Vol. 14, Iss. 5, 2012-10 ,pp. : 299-316

Adis International

Access to resources Recommend Favorite

Targeting the PI3K/AKT/mTOR signaling network in acute myelogenous leukemia

By Martelli Alberto M Evangelisti Camilla Chiarini Francesca Grimaldi Cecilia Manzoli Lucia McCubrey James A

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 9, 2009-09 ,pp. : 1333-1349

Informa Healthcare

Access to resources Recommend Favorite

Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer Development and Progression: Insight to Therapy

Clinical Cancer Drugs, Vol. 3, Iss. 1, 2016-05 ,pp. : 36-62

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer Development and Progression: Insight to Therapy

Clinical Cancer Drugs, Vol. 3, Iss. 1, 2016-03 ,pp. : 36-62

Bentham Science Publishers

Access to resources Recommend Favorite

PI3K/AKT/mTOR Inhibitors In Ovarian Cancer

Current Medicinal Chemistry, Vol. 17, Iss. 36, 2010-12 ,pp. : 4433-4447

Bentham Science Publishers

Access to resources Recommend Favorite